Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Nuclear Medicine/Radiopharmaceuticals Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Nuclear Medicine/Radiopharmaceuticals Market Performance
• 2.3 USA Nuclear Medicine/Radiopharmaceuticals Market Performance
• 2.4 Europe Nuclear Medicine/Radiopharmaceuticals Market Performance
• 2.5 Japan Nuclear Medicine/Radiopharmaceuticals Market Performance
• 2.6 Korea Nuclear Medicine/Radiopharmaceuticals Market Performance
• 2.7 India Nuclear Medicine/Radiopharmaceuticals Market Performance
• 2.8 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Performance
• 2.9 South America Nuclear Medicine/Radiopharmaceuticals Market Performance

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
• 3.2 China Nuclear Medicine/Radiopharmaceuticals Market Performance (Volume)
• 3.3 USA Nuclear Medicine/Radiopharmaceuticals Market Performance (Volume)
• 3.4 Europe Nuclear Medicine/Radiopharmaceuticals Market Performance (Volume)
• 3.5 Japan Nuclear Medicine/Radiopharmaceuticals Market Performance (Volume)
• 3.6 Korea Nuclear Medicine/Radiopharmaceuticals Market Performance (Volume)
• 3.7 India Nuclear Medicine/Radiopharmaceuticals Market Performance (Volume)
• 3.8 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Performance (Volume)
• 3.9 South America Nuclear Medicine/Radiopharmaceuticals Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Cardinal Health
  • 4.1.1 Cardinal Health Profiles
  • 4.1.2 Cardinal Health Product Information
  • 4.1.3 Cardinal Health Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.1.4 Cardinal Health Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.2 Mallinckrodt
  • 4.2.1 Mallinckrodt Profiles
  • 4.2.2 Mallinckrodt Product Information
  • 4.2.3 Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.2.4 Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.3 GE Healthcare
  • 4.3.1 GE Healthcare Profiles
  • 4.3.2 GE Healthcare Product Information
  • 4.3.3 GE Healthcare Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.3.4 GE Healthcare Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.4 Lantheus Medical Imaging
  • 4.4.1 Lantheus Medical Imaging Profiles
  • 4.4.2 Lantheus Medical Imaging Product Information
  • 4.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.5 Bayer
  • 4.5.1 Bayer Profiles
  • 4.5.2 Bayer Product Information
  • 4.5.3 Bayer Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.5.4 Bayer Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.6 Bracco Imaging
  • 4.6.1 Bracco Imaging Profiles
  • 4.6.2 Bracco Imaging Product Information
  • 4.6.3 Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.6.4 Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.7 Eczacibasi-Monrol Nuclear Products
  • 4.7.1 Eczacibasi-Monrol Nuclear Products Profiles
  • 4.7.2 Eczacibasi-Monrol Nuclear Products Product Information
  • 4.7.3 Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.7.4 Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.8 Nordion
  • 4.8.1 Nordion Profiles
  • 4.8.2 Nordion Product Information
  • 4.8.3 Nordion Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.8.4 Nordion Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.9 Advanced Accelerator Applications
  • 4.9.1 Advanced Accelerator Applications Profiles
  • 4.9.2 Advanced Accelerator Applications Product Information
  • 4.9.3 Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.9.4 Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.10 IBA Molecular Imaging
  • 4.10.1 IBA Molecular Imaging Profiles
  • 4.10.2 IBA Molecular Imaging Product Information
  • 4.10.3 IBA Molecular Imaging Nuclear Medicine/Radiopharmaceuticals Business Performance
  • 4.10.4 IBA Molecular Imaging Nuclear Medicine/Radiopharmaceuticals Business Development and Market Status
• 4.20 IBA Molecular Imaging

5 Market Performance for Manufacturers

• 5.1 Global Nuclear Medicine/Radiopharmaceuticals Production (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Global Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Global Nuclear Medicine/Radiopharmaceuticals Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Global Nuclear Medicine/Radiopharmaceuticals Market Performance (Production Point)

• 6.1 Global Nuclear Medicine/Radiopharmaceuticals Production (K Units) and Market Share by Regions 2013-2018
• 6.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue (M USD) and Market Share by Regions 2013-2018
• 6.3 Global Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) by Regions 2013-2018
• 6.4 Global Nuclear Medicine/Radiopharmaceuticals Gross Margin by Regions 2013-2018

7 Development Trend for Regions (Production Point)

• 7.1 Global Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
• 7.2 China Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.3 USA Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.4 Europe Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.5 Japan Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.6 Korea Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.7 India Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.8 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.9 South America Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

8 Global Nuclear Medicine/Radiopharmaceuticals Market Performance (Consumption Point)

• 8.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption and Market Share by Regions 2013-2018
• 8.2 Global Nuclear Medicine/Radiopharmaceuticals Consumption Value and Market Share by Regions 2013-2018
• 8.3 Global Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) by Regions 2013-2018

9 Development Trend for Regions (Sales Point)

• 9.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.2 China Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.3 USA Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.4 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.5 Japan Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.6 Korea Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.7 India Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.8 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.9 South America Nuclear Medicine/Radiopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018

10 Upstream Source, Technology and Cost

• 10.1 Upstream Source
• 10.2 Technology
• 10.3 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Consumer Analysis

• 12.1 Oncology Industry
• 12.2 Thyroid Industry
• 12.3 Cardiology Industry

13 Market Forecast 2019-2024

• 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 13.1.1 Global Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 13.1.2 Global Nuclear Medicine/Radiopharmaceuticals Production (K Units) and Growth Rate 2019-2024
  • 13.1.3 China Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.4 USA Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.5 Europe Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.6 Japan Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.7 Korea Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.8 India Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.9 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.10 South America Nuclear Medicine/Radiopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.2 Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption and Market Share by Regions 2019-2024
  • 13.2.2 Global Nuclear Medicine/Radiopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.3 China Nuclear Medicine/Radiopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.4 USA Nuclear Medicine/Radiopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.5 Europe Nuclear Medicine/Radiopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.6 Japan Nuclear Medicine/Radiopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.7 Korea Nuclear Medicine/Radiopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.8 India Nuclear Medicine/Radiopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.9 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.10 South America Nuclear Medicine/Radiopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
• 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
  • 13.3.1 Overall Market Performance
  • 13.3.2 Diagnostic (SPECT - Technetium, PET - F-18) Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.3 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.4 Sales by Application 2019-2024
  • 13.4.1 Overall Market Performance
  • 13.4.2 Oncology Sales and and Growth Rate 2019-2024
  • 13.4.3 Thyroid Sales and and Growth Rate 2019-2024
  • 13.4.4 Cardiology Sales and and Growth Rate 2019-2024
• 13.5 Price (USD/Unit) and Gross Profit
  • 13.5.1 Global Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) Trend 2019-2024
  • 13.5.2 Global Nuclear Medicine/Radiopharmaceuticals Gross Profit Trend 2019-2024

14 Conclusion

Geographically, global Nuclear Medicine/Radiopharmaceuticals market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Cardinal Health
Mallinckrodt
GE Healthcare
Lantheus Medical Imaging
Bayer
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications
IBA Molecular Imaging

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Diagnostic (SPECT - Technetium, PET - F-18)
Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Nuclear Medicine/Radiopharmaceuticals for each application, including
Oncology
Thyroid
Cardiology
Production, consumption, revenue, market share and growth rate are the key targets for Nuclear Medicine/Radiopharmaceuticals from 2013 to 2024 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.